quantitative
Analysis v1
35
Pro
0
Against

When people use sunscreen heavily, oxybenzone—a common ingredient—gets into the bloodstream more than other sunscreen chemicals, reaching levels more than 500 times higher than what the FDA considers worth checking for safety.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The claim is based on specific quantitative measurements from controlled human pharmacokinetic studies (e.g., FDA 2019 study), which directly measured plasma concentrations of sunscreen ingredients under standardized maximal use conditions. The use of 'geometric mean peak levels' and reference to the FDA threshold are precise and supported by empirical data. The claim does not overstate causation or mechanism—it reports observed concentrations relative to a regulatory benchmark. The verb 'reaches' is appropriately definitive given the direct measurement.

More Accurate Statement

Under maximal use conditions, oxybenzone achieves the highest geometric mean peak plasma concentration among six tested sunscreen active ingredients, with levels exceeding 250 ng/mL in lotion formulations, which is substantially above the FDA’s 0.5 ng/mL safety screening threshold.

Context Details

Domain

medicine

Population

human

Subject

oxybenzone

Action

reaches

Target

the highest plasma concentrations among six tested sunscreen active ingredients, exceeding 250 ng/mL in lotion formulations

Intervention Details

Type: topical sunscreen lotion

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Evidence from Studies

Supporting (1)

35

Contradicting (0)

0
No contradicting evidence found